Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients (APIs), formulations
Wockhardt Limited, is a listed public company incorporated on 08 July, 1999. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 1,125.00 cr and the total paid-up capital is INR 81.25 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Vinesh Kumar Jairath | 00391684 | 9 years |
| Director | Zahabiya Habil Khorakiwala | 00102689 | 8 years |
| Director | Akhilesh Krishna Gupta
Shareholder
|
00359325 | 5 years |
| Whole-time Director | Huzaifa Habil Khorakiwala
Shareholder
|
02191870 | 17 years |
| Whole-time Director | Habil Fakhruddin Khorakiwala
Shareholder
|
00045608 | 26 years |
| Managing Director | Murtaza Habil Khorakiwala
Shareholder
|
00102650 | 17 years |
| Additional Director | Om Prakash Bhatt | 00548091 | 0 years |
| Director | Javed Ahmad | 08668304 | 2 years |
| Director | Amelia Fernandes | 08821072 | 2 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
SBICap Trustee Company Limited
No. of Loans: 1
Total Amount : 951.6 cr
AXIS FINANCE LIMITED
No. of Loans: 1
Total Amount : 200.0 cr
STCI FINANCE LIMITED
No. of Loans: 1
Total Amount : 50.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 13.0 cr
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| WOCKHARDT INFRASTRUCTURE DEVELOPMENT LIMITED | Maharashtra | 1991 | ₹ 2.0 Cr |
| WOCKHARDT MEDICINES LIMITED | Maharashtra | 2019 | ₹ 5.0 L |
| WOCKHARDT BIONOVA LIMITED | Maharashtra | 2021 | ₹ 5.0 L |
| Z&Z Services GmbH | Germany | - | - |
| Morton Grove Pharmaceuticals Inc | Usa | - | - |
| MGP Inc | Usa | - | - |
| Wockhardt France (Holdings) S.A.S | France | - | - |
| Wockhardt Farmaceutica SA DE CV | Mexico | - | - |
| Wockhardt Services SA DE CV | Mexico | - | - |
| Pinewood Healthcare Limited | England & Wales | - | - |
| Wockhardt Bio (R) LLC | Russia | - | - |
| Wockhardt Bio Pty Ltd | Australia | - | - |
| Wockhardt Bio Ltd | New Zealand | - | - |
| CP Pharmaceuticals Limited | England & Wales | - | - |
| Wockhardt Europe Limited | British Virgin Islands | - | - |
| Wockhardt Nigeria Limited | Nigeria | - | - |
| Wockhardt UK Holdings Limited | United Kingdom | - | - |
| CP Pharma (Schweiz) AG | Switzerland | - | - |
| Wallis Group Limited | England & Wales | - | - |
| The Wallis Laboratory Limited | England & Wales | - | - |
| Wockhardt Farmaceutica do Brazil Ltda | Brazil | - | - |
| Wallis Licensing Limited | England & Wales | - | - |
| Wockhardt USA LLC | Usa | - | - |
| Wockhardt Bio AG | Switzerland | - | - |
| Wockhardt UK Limited | England & Wales | - | - |
| Wockpharma Ireland Limited | Ireland | - | - |
| Pinewood Laboratories Limited | Ireland | - | - |
| Wockhardt Holding Corp | Usa | - | - |
Read more
The incorporation date of WOCKHARDT LIMITED is 08 July, 1999
The authorized share capital of WOCKHARDT LIMITED is INR ₹ 1,125.0 Cr.
The paid-up capital of WOCKHARDT LIMITED is INR ₹ 81.2 Cr.
The registered address of WOCKHARDT LIMITED is WOCKHARDT RESEARCH CENTRE, D-4, M.I.D.C. CHIKALTHANA, Aurangabad, AURANGABAD, Maharashtra, India, 431006 - 431006
The CIN number of WOCKHARDT LIMITED is L24230MH1999PLC120720.